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What do we Know About Biomineralization/Calcification? 
 
Including humans, many multicellular organisms produce similar hard tissues such as 
bones, teeth, shells, skeletal units, and spicules. These hard tissues are biocomposites and 
incorporate both structural macromolecules (lipids, proteins, and polysaccharides) and 
inorganic minerals.,1 We do not fully understand the control mechanism of 
biomineralization either in primitive or in developed organisms. The mineral phase of 
hard tissue is sometimes called biological apatite, i.e. a non-stochiometric hydroxyl-
apatite. Pure hydroxyapatite has the formula Ca10(PO4)6(OH)2. In contrast, a biological 
apatite (like in bone) is non-stoichiometric and contains several other ions, mainly 
carbonate and other elements in traces like Mg2+, Na+, Fe2+, HPO42-, F-, Cl-. 
Consequently, a more appropriate structural formula for the composition of bone is 
(Ca,X)10(PO4,CO3,Y)6(OH,Z)2 with X substituting cations and Y and Z substituting 
anions (with the indices 10, 6 and 2 changing according to stoichiometry)., 2 
 
There is a paradox in medicine. While some researchers have been discussing the 
cytotoxic effect of apatite in vitro, 3,4 others have been announcing the safety of in vivo 
apatite applications., 5-8 Although these disagreements have not been completely 
resolved, both biogenic and non-biogenic apatite materials have been continuously used 
in drug delivery and transplantation., 6,9 We know that when apatite is found in soft 
tissue, it is considered to be pathological calcification., 10 Causes of apatite-deposit 
formations in soft tissue have been discussed for decades, but still remain speculative. 
For example, calcification in the coronary arteries has been widely regarded as an 
uncommon, end-stage, insignificant, passive, degenerative process of aging--a notion that 
has paralyzed research in this area for decades., 11 Interestingly, these same terms were 
once used to describe atherosclerosis., 11 Today, we know that coronary artery 
calcification occurs, almost exclusively, at sites of atherosclerotic lesions., 12 
Calcification in the development of these plaques is a complicated, actively regulated 
process of mineralization that is similar to bone formation and remodeling., 13,14 
Mineralogists explain that all that is needed for crystal formation/biomineralization to 
start is nidi (nucleus) and an environment of available dissolved components at or near 
saturation concentrations, along with the absence of inhibitors for crystal formation., 15 
Bacteria or other agents producing such nidi, if present in blood and in urine, are very 
likely candidates to launch and accelerate pathologic calcification in vivo., 16,17 This is 
clinically important since blood contains phosphate near its saturation level., 18  
 
 “Nanobacteria”: Potential Nidi for Calcification, a Good Model for Studying 
Calcification Mechanism 
 
What is known about microbial infections is based on the study of well known microbes.  
There exists a poorly known, blood-born agent (discovered and tentatively termed 
“nanobacteria” (NB) by our team) 19 that behaves as a microbe and appears to show a 
correlation with such diverse calcification-related health problems as arterial heart 
disease, 20-22 Alzheimer’s disease, 23 kidney stone formation, 24-28 polycystic kidney 
disease (PKD), 29,30 gall stones and gallbladder inflammation, 31 prostatitis, 32,33 
calciphylaxis, 34,35 and cancer., 36,37 Furthermore, this agent has unique properties 
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including an extremely small size (0.1-0.5 µm) as seen in Fig 1. Although the biological 
characterization of NB is yet to be fully understood, the precipitation and growth of 
calcium phosphate readily occurs in systems containing trace amounts of NB, but not in 
identical control systems lacking NB., 19 The exact mechanism(s) by which apatite is 
nucleated and formed around NB is unknown.  When the serum concentration in the 
medium is reduced (≤ 5%) in the NB culture conditions, NB start to mineralize and grow 
bigger in size due to calcium and phosphate deposition on their surface (Fig 2). DIC 
microscopy revealed a several-micrometer thick age-ring-like mineral layers forming 
around NB in these cultures (see Fig 2). Chemical analysis using energy-dispersive X-ray 
microanalysis (EDX) of these mineral layers shows Ca and P peaks., 19 The 
effectiveness of NB biomineralization is remarkable: apatite formation in vitro stopped 
only when the calcium level decreased by 50% from 1.8 to 0.9 mM and the phosphate 
levels fell to near zero., 24 Our results indicate that the NB calcium phosphate phase can 
be formed at pH 7.4 consistent with human physiological phosphate and calcium 
concentrations., 19,24,38,39 This can be also monitored by 85Sr incorporation and 
provides a unique model for in vitro studies on calcification., 24 NB-induced apatitic 
biofilm formation is dependent on the presence of oxygen, 19, 40 and can be prevented 
with several antibiotics and anti-metabolites, and by high gamma irradiation at sterilizing 
doses., 39,41  The apatite produced by NB is biogenic because it is formed in a carbon-
containing biomatrix, forms small spherical units of apatite in nanoscale crystal size, (that 
are very resistant to acid hydrolysis), and can be formed at non-saturating concentrations 
of calcium and phosphate., 19 Such spherical units were identified in most human kidney 
stones examined (see Fig. 3)., 24,42,43 Non-biogenic apatite has larger crystals that are 
easily dissolved in acidic solution. Fourier Transform Infrared Spectroscopy (FTIR) of 
NB revealed the mineral as almost identical to bone mineral (Fig. 4). Models for bone 
formation, which use metastable concentrations of calcium and phosphate, involve gels 
that include nidi, such as matrix vesicles, apoptotic vesicles or collagen, but exclude the 
known proteinaceous inhibitors for crystal formation., 44 Such systems have not been 
tested with nanobacteria. Vali et al. have shown that nanoforms contain apatite-protein 
complexes and immuno electron microscopy reveals protein antigens in proximity to 
apatite suggesting a novel form of protein-associated mineralization., 45  
 
In our earlier studies, we examined NB cultures in High Aspect Rotating Vessels 
(HARVs) designed at the NASA’s Johnson Space Center, which are designed to simulate 
some aspects of microgravity., 25  NB cultured in HARVs multiplied 4.6 times faster 
than under stationary conditions and 3.2 times faster than in shaker flask incubation. 
Interestingly, the results demonstrated that the degree of apatite crystal formation on NB 
(biomineralization) and the properties of the apatite are strongly affected by the gravity 
and other specific culture conditions used., 25  Although some researchers believe that 
microgravity does not affect crystal formation and biomineralization, 46 it has been 
shown that long periods in a microgravity environment does cause loss of bone, and 
enhance kidney stone formation-like biomineralization disorders in astronauts., 47-49 
 
In summary, NB is a perfect model for studying biogenic mineralization/calcification 
because NB a) are self-replicating particles and have less complicated metabolic 
pathways b) accumulate calcium and phosphate under physiological conditions, c) 
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produce a calcium phosphate mineral similar to bone, d) exist in physical conditions (pH, 
gravity, temperature, etc) that are easy to manipulate, and which can be replicated for the 
physiological model.  
 
Controversy 
 
The first debate about NB revolved around whether these minute particles are alive or 
not. To this day, critics argue that a particle just 50 to 200 nanometers in diameter can't 
possibly harbor the components necessary to sustain life. Maniloff's work suggests that to 
contain the DNA and proteins needed to function, a cell must be at least 140 nanometers 
across., 50 However, recently it has been shown that a genome constructed to encode 387 
protein-coding and 43 structural RNA genes could sustain a viable synthetic cell, a 
Mycoplasma laboratorium which can shrink its size below that limitation., 51 NB are 
also incredibly resistant to heat and other methods that would normally kill bacteria, 
which makes some scientists wonder if they might be an unusual form of crystal rather 
than organisms. Cisar et al, presented an alternative theory for the experimental findings 
of NB scientist. They stated that biomineralization previously attributed to NB may be 
initiated by nonliving macromolecules and transferred on "subculture" by self-
propagating microcrystalline apatite., 52 
 
Detection Methods for NB 
 
Methods to diagnose NB in biologicals, cells, tissues, blood and urine include 
immunodetection with NB-specific monoclonal antibodies, electron microscopy and 
culture techniques., 39,53 Because NB pass through 0.22 µm pore size filters, which 
exclude most common microbes, filtration is often used to clean up fluid specimens 
before culture for NB., 53 Replication can be measured by particle counting and optical 
density at 650 nm., 41 It has been also shown that growth of the NB could be detected by 
specific methods, such as ELISA, turbidity, SDS-PAGE or methionine and uridine 
incorporation., 19,20 Susceptibility tests can be used to test effects of antibiotics and 
other chemotherapeutics., 19  Growth could be prevented with tetracycline, high doses of 
aminoglycoside antibiotics, EDTA, cytosine arabinoside, 5-FU and gamma-irradiation., 
19 
 
Are NB a Living Entity? 
 
Isolation of any kind of nucleic acid from NB has been difficult, in part because of the 
mineral surface that they produced during their culture period. They could not be lysed 
with lysozyme, proteinase K, several other proteinases, lipases, amylases, alkali, 
ultrasound, X-press, detergents or solvents., 40 We needed to use acid or EDTA like 
chelators before the analysis, which were the factors for structural change in nucleic acid.  
It has been our experience that NB actually inhibit the amplification of added exogeneous 
classical bacterial DNA by polymerase chain reaction methods. 
 
In a preliminary research, NB cultures incorporated increasing amounts of radiolabel S35 
into macromolecules separable by gel electrophoresis during the 18-day incubation 
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period. Protein pattern detected with Coomassie stain of SDS-PAGE transferred to an 
Immobilon membrane and autoradiography showed methionine incorporation into several 
proteins (Fig. 5). Miller et al showed that autoradiographs of isolated NB nucleic acid 
indicated incorporation of uridine into several “nucleic acid” bands., 20 The negative 
control, media containing gamma-irradiated serum (ie., inactivated NB), did not yield 
radioactive bands after exposure to these radiolabeled DNA/RNA and protein precursors.  
In order to define the mechanism of incorporation, and systematic location of NB, further 
molecular research is needed. 
 
Are Nanobacteria Cytotoxic? 
 
Calcified and non-calcified forms of NB have been observed as free, cell-attached and 
internalized particles in mammalian cell cultures in vitro., 19,53 In our experiments we 
have chosen 6 different fibroblast lines as experimental models, because they are the 
most ubiquitous cells in the animal body and might be most accessible in wound tissue 
for invading pathogens with the exception of professional phagocytic leucocytes., 53  We 
have shown that NB were bound as clusters on the cell surfaces within 15 minutes. It is 
concluded that NB are internalized either by receptor-mediated endocytosis or by a 
closely related pathway within 12 hours., 53 Internalization seems to be necessary for 
cytotoxicity. We showed that cytotoxicity was dependent on NB concentration and 
exposure time. Dying cells always contained numerous ingested NB., 53 Hybridomas and 
many lymphocytes were found to be affected by NB, but considerably higher doses were 
needed., 40,53 The findings that NB are cytotoxic are of interest to nanoparticle toxicity 
mechanisms in general: similar mechanisms could be used by other nanoparticles for 
entering cells and causing cytotoxicity., 54 
 
In vivo Effects of NB 
 
Akerman et al. reported that radiolabeled (99mTc) viable NB accumulated in the kidney 
and appeared in urine after 15 minutes of their intravenous injection into rabbits. This 
could be due to the fact that kidneys are the preferred sides for this agent, unlike other 
known nanoparticles, and the presence of injured epithelium or a nucleus in the 
kidney/urinary tract provides a preferable niche for NB to adhere and grow, resulting in 
biocrystallization., 55 A control study in rabbit was performed administering a similar 
dose of 99mTc-labelled albumin cross-linked particles or tin-technetium nanoparticles as 
nanocolloids. Nanocolloids were not targeted to kidneys as NB were., 55 Shiekh et al too 
observed that NB, when injected intravenously into rats, were localized in kidneys., 28 In 
their research they observed regions of chronic inflammation infiltrated in the cortex and 
medulla, which could be due to damage induced by NB. The research team has also 
shown NB adhering to the surface of the epithelium and their penetration into the 
epithelial cells. 
  
NB and Connections to Calcification Related Diseases 
 
Calcium is the most important intracellular regulator of physiological responses and is a 
messenger for hormonal actions and as well regulates cell death and multiplication. 
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Additionally, calcium regulates inflammation, blood clotting, immunological responses 
and neural transmitting and muscle contraction. In these actions calcium-binding proteins 
are the main players. Recently, a large number of calcium-binding proteins have been 
mapped to be bound on NB., 56 NB may thus participate in activation – inhibition 
processes regulating a large number of responses inside and outside cells. Thus, NB 
could have multiple pathological actions in the body. 
 
The life-long prevalence of kidney stones appears to have increased throughout the whole 
20th century and occurs in up to 15% of the population., 57  Treatment of kidney stones is 
now estimated to cost over $3000 per patient per year.  The incidence of new cases and 
recurrences may continue to rise. Thus, new approaches in treatment and prevention 
could have a huge economic effect apart from benefits in terms of reduced morbidity.  
Electron microscopic observations show that apatite units produced in serum-free NB 
cultures are very similar to human apatitic kidney stones (Figs. 2 and 3). Both grow as 
layers of mineral (Fig. 2) and matrix. Chemical analysis, EDX, revealed that the 
composition of this solid mineral formation was similar to that of most extraskeletal 
tissue calcification and stones., 19 The crystalline components of kidney stones are 
calcium oxalate, calcium phosphate, struvite, purines, or cystine., 58 Fermentor model 
studies have shown that in kidney stones calcium phosphate nidi are always formed 
initially and may subsequently become coated with oxalate or other components., 59,60 
Apparently, apatite may play a key role in the formation of all kidney stones. Our 
hypothesis underlines the role of active nidi: even supersaturated urine needs nidi for 
crystallization to appear, and active nidi could make the process more thermo-
dynamically favoured, so that it could happen apparently outside equilibrium. We have 
proposed that NB may be active nidi that attach to, invade and damage urinary epithelium 
of collecting ducts and papilla forming calcium phosphate center(s)., 19,24-27,30 We 
found NB in 70 out of 72 human kidney stones studied in Finland., 24 Khullar et al 
demonstrated 62% culture positivity of NB in stones collected from an Indian 
population., 61 Additionally, they showed DNA and distinct protein bands of NB. 
However, one group has been unsuccessful at replicating NB culture from stones 
although they have observed nanoparticles morphologically similar to NB in SEM 
analysis., 62  
 
Another urinary disease, PKD, is the most common autosomal dominant lethal disease in 
humans. There are reports of endotoxin, NB, and fungal antigens and antibodies in 
human kidney cyst fluids. Interestingly, a higher prevalence of kidney calcifications is 
observed in PKD than in the normal population., 63 It has been proposed that the 
currently known cellular toxicities, tissue distribution, and pharmacology of NB are 
plausibly related to the known pathology and pharmacology of PKD., 29 Hjelle et al 
evaluated 13 PKD cyst fluids and detected NB antigen positivity in each sample as well 
as in liver cystic fluid from affected individuals., 29 
 
Biopsies, urine, and prostatic secretion cultures fail to demonstrate bacterial pathogens 
more frequently than in asymptomatic controls, yet inflammation or at least inflammatory 
markers are often detected in chronic prostatitis., 64 Likewise, the presence of prostatic 
calculi in younger men is associated with both inflammation and symptoms of chronic 
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pelvic pain syndrome., 65, 66 The core of prostatic calculi is typically calcium apatite, 67 
which is the hallmark of NB action. Wood et al, proposed that there is a potential role of 
NB in chronic prostatitis., 32 Recent clinical research targeting these agents has proven 
effective in treating some patients with refractory category III prostatitis (chronic pelvic 
pain syndrome)., 33 In that research, NB antigen or antibody was found in 60% of serum 
and 40% of urine samples. In 10 patients who underwent transrectal ultrasound after 
therapy, prostatic stones were decreased in size or resolved in 50%., 33 
 
Mechanisms mediating vascular calcification remain incompletely understood. Some 
have hypothesized the potential role of NB in arterial calcification., 20,21,35 Miller et al, 
cultured nanosized particles from calcified but not from noncalcified aneurysms. These 
particles were stained with Nb-specific monoclonal antibodies, recognized by a DNA-
specific dye and incorporated radiolabeled uridine, and, after decalcification, they 
appeared via electron microscopy to contain cell walls., 20 Therefore, nanometer-scale 
particles similar to those described as nanobacteria isolated from geological specimens 
and human kidney stones can be visualized in and cultured from calcified human 
cardiovascular tissue., 20 Puskas et al, propagated NB- like spherical particles from 26 of 
42 sclerotic aorta and carotid samples and confirmed their nature by dot immunoblot by 
using Nb-specific monoclonal antibodies, light microscopy and TEM. [3H]L-aspartic 
acid was incorporated into high molecular weight compounds of demineralized particles. 
PCR amplification of 16S rDNA sequences from the particles was unsuccessful using 
traditional protocols., 21 Identification of NB-like particles at the lesion supports, but 
does not by itself prove the hypothesis that these agents contribute to the pathogenesis of 
atherosclerosis, especially vascular calcifications. Specific therapies targeting these 
particles has demonstrated reduced plaque formation, regression of plaques, and 
improved lipid profiles., 68 The potential of anti-NB treatments are controversial and 
await larger clinical trials. Epidemiological studies have implicated antibodies made by 
the body against NB to be a strong independent risk factor for coronary artery 
calcification. The risk appears to be comparable to that of diabetes in the two preliminary 
studies., 69,70 The importance of this is that coronary artery calcification is an excellent 
predictor of future coronary events and death. 
 
 
Originally, Sedivy and Battistutti reported that NB promoted crystallization of 
psammoma bodies in ovarian cancer., 71 Hudelist et al. soon verified the  100% 
concordance between the expression of NB and the presence of psammoma bodies in 
malignant ovarian tumours. In their research, several lines of evidence suggest the 
involvement of these organisms in the process of biomineralization. Therefore they have 
concluded that NB infection of malignant ovarian tissue contributes to mechanisms 
leading to the formation of calcified deposits known as psammoma bodies., 36  
 
Additionally, NB have been shown to be detected at higher rates in serum of patients with 
gallstone disease, 31 and mitral valve calcification., 34 Others have suggested that NB 
may contribute to the development of peripheral neutropathy in HIV positive patients, 
72,73 and periodontal problems, 22,74 and even osteoporosis., 75 All these hypothetical 
approaches require further investigation. 
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Koch’s Postulates 
 
In a small study, Garcia Cuerpo et al found that translumbar, percutaneous intrarenal 
injection of NB (isolated from kidney stones) into rats resulted in kidney stone 
formation., 76 Additionally, Shiekh et al has examined NB’s role in biocrystallization 
and in vivo effects on kidney pathology. Calcium oxalate monohydrate assay (COM) was 
carried out in the presence of NB to study biocrystallization. Wistar rats were given an 
intravenous injection of NB and the kidneys were examined for pathological changes. 
The COM assay showed accelerated biocrystallization of (14)C-oxalate in the presence of 
NB, indicating them to be efficient candidates for biomineralization. Histopathological 
studies revealed bacteria induced renal tubular calcifications and various manifestations 
of infection., 28 Their studies confirm that NB may be involved in the pathogenesis of 
renal tubular calcification. Such findings are required to prove Koch’s postulates linking 
NB to other pathological calcification related diseases. 
 
Conclusion 
 
Whether NB themselves serve as the nucleus for crystal formation, or whether the NB are 
simply able to lower the activation energy barrier and thus allow precipitation and growth 
of crystals under much lower supersaturation conditions is yet to be determined. 
However, it is immaterial whether or not they are bacteria, viruses, or other living or 
nonliving forms; their properties of promoting ready crystallization and growth of Ca 
minerals are well established. These self-replicating particles may induce calcification 
and stone formation in vivo because: NB a) have been detected in human blood, b) are 
transported from blood into urine and bile as living organisms, c) are renotropic, d) cause 
apoptotic cell death, e) are present in human stone-isolates, and tissues with calcification, 
f) cause kidney stone formation in rats within one month when injected in an intra-renal 
route. 
 
Since NB have been detected in blood and blood products, they should be of interest to 
the biopharmaceutical industry. For example recently, NB have been isolated and 
cultured from the cultured nasopharyngeal carcinoma epithelia HNE1 cell supernatant., 
77 Safety of vaccines produced in cell culture by using (bovine) serum or serum-derived 
materials in culture of the cells, sterilized by filtration is  an issue needing thorough risk 
analysis and method validation., 78,79 
 
Only continued research will reveal the nature of NB and their impact on health and 
disease. NB are a good model system to use in developing drugs to alter the likely diverse 
pathways involved in tissue calcification.  While the controversy of whether they are 
living or nonliving entities will continue until new definitive data is collected, this 
controversy should not overshadow the critical medical importance of understanding the 
already demonstrated effects of NB on pathologic calcification in the human body and on 
research into countermeasures to reverse or eliminate these effects. 
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Figure 1. Scanning Electron Microscopic (left), and Transmission Electron Microscopic 
(right) images of cultured nanobacteria (NB). Arrows on the right show apatite envelop 
of apparently multiplying NB. Bars; 100nm left, 50nm right 
 
 
 
 
Figure 2. SEM (left), and DIC (right) image of an apatite clusters formed by NB under 
serum-free culture conditions. Arrows on the right show age-ring like apatite layers on 
around NB “colonies”. Bars, 5 micrometers. 
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Figure 3. SEM image of spherical apatite 
formations in an apatite kidney stone. Bar 10 
micrometers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 NB 
 
 
 
 
 
Figure. 4. FTIR results showing the distinct phosphate absorption signature at 1000 to 
1200 cm-1 is seen in all four spectra, with inorganic apatite, bone, kidney stones and NB.   
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Figure 5. Metabolic labeling of NB. Images showing incorporation of radiolabeled 
precursor  molecule into macromolecules. 
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